QUADRANT CAPITAL GROUP LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 214 filers reported holding SAGE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$14,180
+618.0%
689
+1540.5%
0.00%
Q2 2023$1,975
-24.1%
42
-32.3%
0.00%
Q1 2023$2,602
+62.4%
62
+47.6%
0.00%
Q4 2022$1,602
-46.6%
42
-37.3%
0.00%
Q3 2022$3,000
+50.0%
670.0%0.00%
Q2 2022$2,000
+100.0%
67
+168.0%
0.00%
Q1 2022$1,000
-66.7%
25
-57.6%
0.00%
Q4 2021$3,000
+200.0%
59
+110.7%
0.00%
Q3 2021$1,000
-66.7%
28
-53.3%
0.00%
Q2 2021$3,000
-40.0%
60
-13.0%
0.00%
-100.0%
Q1 2021$5,000
-28.6%
69
-14.8%
0.00%0.0%
Q4 2020$7,000
+75.0%
81
+22.7%
0.00%0.0%
Q3 2020$4,000
+300.0%
66
+164.0%
0.00%
Q2 2020$1,000
-66.7%
25
-77.3%
0.00%
-100.0%
Q1 2020$3,000110
+1471.4%
0.00%
Q4 2019$0
-100.0%
7
-96.0%
0.00%
-100.0%
Q3 2019$23,000
-62.9%
176
-49.4%
0.00%
-60.0%
Q2 2019$62,000
+17.0%
3480.0%0.01%
+11.1%
Q1 2019$53,000348
+4871.4%
0.01%
Q4 2018$070.00%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Integral Health Asset Management, LLC 311,000$10,294,0002.68%
Palo Alto Investors LP 851,719$28,192,0002.18%
Boxer Capital, LLC 1,094,000$36,211,0001.86%
DAFNA Capital Management LLC 180,306$5,968,0001.56%
Deep Track Capital, LP 675,000$22,343,0001.43%
Bellevue Group AG 3,052,404$101,034,0001.17%
Ikarian Capital, LLC 249,907$8,272,0001.09%
Ikarian Capital, LLC 250,000$8,275,0001.09%
Artal Group S.A. 750,000$24,825,0001.04%
SECTOR GAMMA AS 118,476$3,922,0000.85%
View complete list of SAGE THERAPEUTICS INC shareholders